A Darwinian-evolutionary concept of age-related diseases

Experimental Gerontology

Volumn 38, Issue 1-2, 2003, Pages 13-25

  Wick, Georg ^a,b   Berger, Peter ^a   Jansen Dürr, Pidder ^a   Grubeck Loebenstein, Beatrix ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Alzheimer's disease; Atherosclerosis; Cancer; Pleiotropic antagonism; Prostate

Indexed keywords

ALZHEIMER DISEASE; ATHEROSCLEROSIS; CANCER; CELL AGING; CELLULAR IMMUNITY; CONFERENCE PAPER; DEGENERATIVE DISEASE; EVOLUTION; GENETIC TRAIT; HUMAN; IMMUNE SYSTEM; INFLAMMATORY DISEASE; LIFE EXPECTANCY; NONHUMAN; PERSONAL HYGIENE; PLEIOTROPY; POLITICS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REPRODUCTION; SEXUAL BEHAVIOR; SOCIOECONOMICS;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ANIMALS; ARTERIOSCLEROSIS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; EVOLUTION; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIFACTORIAL INHERITANCE; OXIDATIVE STRESS; PROSTATIC HYPERPLASIA; REPRODUCTION; STEM CELLS; TELOMERASE;

ANIMALIA; DARWINIA;

EID: 0037242639     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(02)00161-4     Document Type: Conference Paper

References (101)

1. Amberger A., Maczek C., Jürgens G., Michaelis D., Schett G., Trieb K., Eberl T., Jindal S., Xu Q., Wick G. Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress Chaperones. 2:1997;94-103.
2. Artandi S.E., DePinho R.A. A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr. Opin. Genet. Dev. 10:2000;39-46.
3. Barger S.W., Hörster D., Furukawa K., Goodman Y., Krieglstein J., Mattson M.P. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc. Natl Acad. Sci. USA. 92:1995;9328-9332.
4. Baxter R.C. Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol. Pathol. 54:2001;145-148.
5. Bennett M.R., Macdonald K., Chan S.W., Boyle J.J., Weissberg P.L. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ. Res. 82:1998;704-712.
6. Birnie D.H., Holme E.R., McKay I.C., Hood S., McColl K.E., Hillis W.S. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur. Heart J. 19:1998;387-394.
7. Blasko I., Marx F., Steiner E., Hartmann T., Grubeck-Loebenstein B. TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs. FASEB J. 13:1999;63-68.
8. Bonkhoff H., Remberger K. Morphogenetic concepts of normal and abnormal growth in the human prostate. Virchows Arch. 433:1998;195-202.
9. Campisi J. The role of cellular senescence in skin aging. J. Investig. Dermatol. Symp. Proc. 3:1998;1-5.
10. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11:2001;S27-S31.
11. Castillo G.M., Cummings J.A., Ngo C., Yang W., Snow A.D. Novel purification and detailed characterization of perlecan isolated from the Engelbreth-Holm-Swarm tumor for use in an animal model of fibrillar A beta amyloid persistence in brain. J. Biochem. (Tokyo). 120:1996;433-444.
12. 2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication. Biochem. J. 332:1998;43-50.
13. Du Y., Dodel R., Hampel H., Buerger K., Lin S., Eastwood B., Bales K., Gao F., Moeller H.J., Oertel W., Farlow M., Paul S. Reduced levels of amyloid beta-peptide antibody in Alzheimer disease. Neurology. 57:2001;801-805.
14. Elan-press release. Elan and Wyeth provide update on status of Alzheimer's collaboration (online). Available from URL: http://www.elan.com/research/alzheimer/ (accessed 2002 March 04).
15. Flanders K.C., Ren R.F., Lippa C.F. Transforming growth factor-betas in neurodegenerative disease. Prog. Neurobiol. 54:1998;71-85.
16. Forsyth N.R., Wright W.E., Shay J.W. Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation. 69:2002;188-197.
17. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:1994;2493-2503.
18. George J., Afek A., Gilburd B., Levkovitz H., Shaish A., Goldberg I., Kopolovic Y., Wick G., Shoenfeld Y., Harats D. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis. 138:1998;147-152.
19. Goldgaber D., Harris H.W., Hla T., Maciag T., Donnelly R.J., Jacobsen J.S., Vitek M.P., Gajdusek D.C. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Natl Acad. Sci. USA. 86:1989;7606-7610.
20. Goldstein S., Moerman E.J., Baxter R.C. Accumulation of insulin-like growth factor binding protein-3 in conditioned medium of human fibroblasts increases with chronologic age of donor and senescence in vitro. J. Cell. Physiol. 156:1993;294-302.
21. Goodman L., Stein G.H. Basal and induced amounts of interleukin-6 mRNA decline progressively with age in human fibroblasts. J. Biol. Chem. 269:1994;19250-19255.
22. Grigoriev V.G., Moerman E.J., Goldstein S. Overexpression of insulin-like growth factor binding protein-3 by senescent human fibroblasts: attenuation of the mitogenic response to IGF-I. Exp. Cell Res. 219:1995;315-321.
23. Grubeck-Loebenstein B., Blasko I., Marx F., Trieb K. Immunization with beta-amyloid: could T-cell activation have a harmful effect? Trends Neurosci. 23:2000;114.
24. Gruber R., Lederer S., Bechtel U., Lob S., Riethmüller G., Feucht H.E. Increased antibody titers against mycobacterial heat-shock protein 65 in patients with vasculitis and arteriosclerosis. Int. Arch. Allergy Immunol. 110:1996;95-98.
25. Hansson G.K., Jonasson L., Seifert P.S., Stemme S. Immune mechanisms in atherosclerosis. Arteriosclerosis. 9:1989;567-578.
26. Hayflick L. Aging, longevity, and immortality in vitro. Exp. Gerontol. 27:1992;363-368.
27. Hermann M., Berger P. Aging of the male endocrine system. Rev. Physiol. Biochem. Pharmacol. 139:1999;89-122.
28. Hermann M., Untergasser G., Rumpold H., Berger P. Aging of the male reproductive system. Exp. Gerontol. 35:2000;1267-1279.
29. Hoppichler F., Lechleitner M., Traweger C., Schett G., Dzien A., Sturm W., Xu Q. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis. 126:1996;333-338.
30. Huo Y., Ley K. Adhesion molecules and atherogenesis. Acta Physiol. Scand. 173:2001;35-43.
31. Hyman B.T., Smith C., Buldyrev I., Whelan C., Brown H., Tang M.X., Mayeux R. Autoantibodies to amyloid-beta and Alzheimer's disease. Ann. Neurol. 49:2001;808-810.
32. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., Chishti M.A., Horne P., Heslin D., French J., Mount H.T., Nixon R.A., Mercken M., Bergeron C., Fraser P.E., St George-Hyslop P., Westaway D. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 408:2000;979-982.
33. Jeohn G.H., Kong L.Y., Wilson B., Hudson P., Hong J.S. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J. Neuroimmunol. 85:1998;1-10.
34. Jones D.B., Coulson A.F., Duff G.W. Sequence homologies between hsp60 and autoantigens. Immunol. Today. 14:1993;115-118.
35. Keller J.N., Kindy M.S., Holtsberg F.W., St Clair D.K., Yen H.C., Germeyer A., Steiner S.M., Bruce-Keller A.J., Hutchins J.B., Mattson M.P. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18:1998;687-697.
36. Kiechl S., Egger G., Mayr M., Wiedermann C.J., Bonora E., Oberhollenzer F., Muggeo M., Xu Q., Wick G., Poewe W., Willeit J. Chronic infections and the risk of carotid atherosclerosis. Prospective results from a large population study. Circulation. 103:2001;1064-1070.
37. Kleindienst R., Xu Q., Willeit J., Waldenberger F.R., Weimann S., Wick G. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing α/β or γ/δ receptor in human atherosclerotic lesions. Am. J. Pathol. 142:1993;1927-1937.
38. Kol A., Lichtman A.H., Finberg R.W., Libby P., Kurt-Jones E.A. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J. Immunol. 164:2000;13-17.
39. Krieg M., Nass R., Tunn S. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. J. Clin. Endocrinol. Metab. 77:1993;375-381.
40. Krtolica A., Parrinello S., Lockett S., Desprez P.Y., Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl Acad. Sci. USA. 98:2001;12072-12077.
41. Lee C., Sintich S.M., Mathews E.P., Shah A.H., Kundu S.D., Perry K.T., Cho J.S., Ilio K.Y., Cronauer M.V., Janulis L., Sensibar J.A. Transforming growth factor-beta in benign and malignant prostate. Prostate. 39:1999;285-290.
42. Li Y.M., Xu M., Lai M.T., Huang Q., Castro J.L., DiMuzio-Mower J., Harrison T., Lellis C., Nadin A., Neduvelil J.G., Register R.B., Sardana M.K., Shearman M.S., Smith A.L., Shi X.P., Yin K.C., Shafer J.A., Gardell S.J. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature. 405:2000;689-694.
43. Loughran O., Malliri A., Owens D., Gallimore P.H., Stanley M.A., Ozanne B., Frame M.C., Parkinson E.K. Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene. 13:1996;561-568.
44. Madersbacher S., Haidinger G., Temml C., Schmidbauer C.P. Prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2096 men. Eur. Urol. 34:1998;136-141.
45. Maier J.A., Statuto M., Ragnotti G. Senescence stimulates U937-endothelial cell interactions. Exp. Cell Res. 208:1993;270-274.
46. Matsushita H., Chang E., Glassford A.J., Cooke J.P., Chiu C.P., Tsao P.S. eNOS activity is reduced in senescent human endothelial cells: preservation by hTERT immortalization. Circ. Res. 89:2001;793-798.
47. Mattson M.P., Cheng B., Baldwin S.A., Smith-Swintosky V.L., Keller J., Geddes J.W., Scheff S.W., Christakos S. Brain injury and tumor necrosis factors induce calbindin D-28k in astrocytes: evidence for a cytoprotective response. J. Neurosci. Res. 42:1995;357-370.
48. Marx F., Blasko I., Pavelka M., Grubeck-Loebenstein B. The possible role of the immune system in Alzheimer's disease. Exp. Gerontol. 33:1998;871-881.
49. Mayr M., Metzler B., Kiechl S., Willeit J., Schett G., Xu Q., Wick G. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae. Immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation. 99:1999;1560-1566.
50. Mayr M., Kiechl S., Willeit J., Wick G., Xu Q. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid of femoral atherosclerosis. Circulation. 102:2000;833-839.
51. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 21:1995;195-218.
52. Millis A.J., Hoyle M., McCue H.M., Martini H. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp. Cell Res. 201:1992;373-379.
53. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D., Connor K., Hatcher J., Hope C., Gordon M., Arendash G.W. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408:2000;982-985.
54. Morimoto R.I. Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev. 12:1998;3788-3796.
55. Naslund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P., Buxbaum J.D. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA. 283:2000;1571-1577.
56. Nesse R.M., Williams G.C. Evolution and Healing. The New Science of Darwinian Medicine. 1995;Weidenfeld & Nicolson, UK.
57. Nesse R.M., Williams G.C. Evolution and the origins of disease. Sci. Am. 279:1998;86-93.
58. Nevalainen M.T., Valve E.M., Ingleton P.M., Nurmi M., Martikainen P.M., Harkonen P.L. Prolactin and prolactin receptors are expressed and functioning in human prostate. J. Clin. Invest. 99:1997;618-627.
59. Olshansky S.J., Carnes B.A., Butler R.A. If humans were built to last. Sci. Am. 284:2001;50-55.
60. Olshansky S.J., Hayflick L., Carnes B.A. No truth to the fountain of youth. Sci. Am. 286:2002;78-81. see http://www.sciam.com/explore_directory.cfm 'The truth about human aging'.
61. Paradis E., Douillard H., Koutroumanis M., Goodyer C., LeBlanc A. Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons. J. Neurosci. 16:1996;7533-7539.
62. Peehl D.M., Sellers R.G. Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells. Exp. Cell Res. 232:1997;208-215.
63. Rao M.S., Mattson M.P. Stem cells and aging: expanding the possibilities. Mech. Ageing Dev. 122:2001;713-734.
64. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
65. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
66. Rumpold H., Untergasser G., Madersbacher S., Berger P. The development of benign prostatic hyperplasia by trans-differentiation of prostatic stromal cells. Exp. Gerontol. 37:2002;1001-1004.
67. Sachs D.L., Marghoob A.A., Halpern A. Skin cancer in the elderly. Clin. Geriatr. Med. 17:2001;715-738. vii.
68. Saunders N.A., Smith R.J., Jetten A.M. Regulation of proliferation-specific and differentiation-specific genes during senescence of human epidermal keratinocyte and mammary epithelial cells. Biochem. Biophys. Res. Commun. 197:1993;46-54.
69. Schedlich L.J., Young T.F., Firth S.M., Baxter R.C. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J. Biol. Chem. 273:1998;18347-18352.
70. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., Seubert P. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400:1999;173-177.
71. Schett G., Xu Q., Amberger A., Van Der Zee R., Recheis H., Willeit J., Wick G. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J. Clin. Invest. 96:1995;2569-2577.
72. Schett G., Metzler B., Kleindienst R., Amberger A., Recheis H., Xu Q., Wick G. Myocardial injury leads to a release of heat shock protein (HSP) 60 and a suppression of the anti-hsp65 immune response. Cardiovasc. Res. 42:1999;685-695.
73. Schmitt T.L., Steger M.M., Pavelka M., Grubeck-Loebenstein B. Interactions of the Alzheimer beta amyloid fragment (25-35) with peripheral blood dendritic cells. Mech. Aging Dev. 94:1997;223-232.
74. Sensibar J.A., Pruden S.J., Kasjanski R.Z., Rademaker A., Lee C., Grayhack J.T., Kozlowski J.M. Differential growth rates in stromal cultures of human prostate derived from patients of varying ages. Prostate. 38:1999;110-117.
75. Shay J.W., Wright W.E. Ageing and cancer: the telomere and telomerase connection. Novartis Found. Symp. 235:2001;116-125.
76. Soltys B.J., Gupta R.S. Cell surface localization of the 60 kDa heat shock chaperonin protein (hsp60) in mammalian cells. Cell Biol. Int. 21:1997;315-320.
77. Stein G.H., Dulic V. Origins of G(1) arrest in senescent human fibroblasts. BioEssays. 17:1995;537-543.
78. Stemme S., Rymo L., Hansson G.K. Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab. Invest. 65:1991;654-660.
79. Tamatani M., Che Y.H., Matsuzaki H., Ogawa S., Okado H., Miyake S., Mizuno T., Tohyama M. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274:1999;8531-8538.
80. Trieb K., Ransmayr G., Sgonc R., Lassmann H., Grubeck-Loebenstein B. APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's disease. Neurobiol. Aging. 17:1996;541-547.
81. Untergasser G., Rumpold H., Hermann M., Dirnhofer S., Jilg G., Berger P. Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors. Exp. Gerontol. 34:1999;275-287.
82. Untergasser G., Rumpold H., Plas E., Madersbacher S., Berger P. A low-molecular-weight fraction of human seminal plasma activates adenylyl cyclase and induces caspase 3-independent apoptosis in prostatic epithelial cells by decreasing mitochondrial potential and Bcl-2/Bax ratio. FASEB J. 15:2001;673-683.
83. Untergasser G., Rumpold H., Plas E., Witkowski M., Berger P. Seminal plasma factors induce in vitro PRL secretion in smooth muscle cells of the human prostate. J. Clin. Endocrinol. Metab. 86:2001;5577-5584.
84. Vickers J.C., Dickson T.C., Adlard P.A., Saunders H.L., King C.E., McCormack G. The cause of neuronal degeneration in Alzheimer's disease. Prog. Neurobiol. 60:2000;139-165.
85. Wagner M., Hampel B., Bernhard D., Hala M., Zwerschke W., Jansen-Dürr P. Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp. Gerontol. 36:2001;1327-1347.
86. Wick G., Kleindienst R., Dietrich H., Xu Q. Is atherosclerosis an autoimmune disease? Trends Food Sci. Technol. 3:1992;114-119.
87. Wick G., Schett G., Amberger A., Kleindienst R., Xu Q. Is atherosclerosis an immunologically mediated disease? Immunol. Today. 16:1995;27-33.
88. Wick G., Jansen-Dürr P., Berger P., Blasko I., Grubeck-Loebenstein B. Diseases of aging. Vaccine. 18:2000;1567-1583.
89. Wick G., Perschinka H., Millonig G. Atherosclerosis as an autoimmune disease: an update. Trends Immunol. 22:2001;665-669.
90. Wick G. 'Anti-aging' medicine: does it exist? A critical discussion of 'anti-aging health products'. Exp Gerontol. 37:2002;1137-1140.
91. Wraight C.J., Liepe I.J., White P.J., Hibbs A.R., Werther G.A. Intranuclear localization of insulin-like growth factor binding protein-3 (IGFBP-3) during cell division in human keratinocytes. J. Invest. Dermatol. 111:1998;239-242.
92. Xu Q., Oberhuber G., Gruschwitz M., Wick G. Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks and atherosclerotic plaques in young and aged human specimens. Clin. Immunol. Immunopathol. 56:1990;344-359.
93. Xu Q., Dietrich H., Steiner H.J., Gown A.M., Schoel B., Mikuz G., Kaufmann S.H.E., Wick G. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler. Thromb. 12:1992;789-799.
94. Xu Q., Willeit J., Marosi M., Kleindienst R., Oberhollenzer F., Kiechl S., Stulnig T., Luef G., Wick G. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis (+Editorial). Lancet. 341:1993;255-259.
95. Xu Q., Kleindienst R., Waitz W., Dietrich H., Wick G. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J. Clin. Invest. 91:1993;2693-2702.
96. Xu Q., Schett G., Seitz C.S., Hu Y., Gupta R.S., Wick G. Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells. Circ. Res. 75:1994;1078-1085.
97. Xu Q., Kiechl S., Mayr M., Metzler B., Egger G., Oberhollenzer F., Willeit F., Wick G. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis (+Editorial). Circulation. 100:1999;1169-1174.
98. Xu Q., Schett G., Perschinka H., Mayr M., Egger G., Oberhollenzer F., Willeit J., Kiechl S., Wick G. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation. 101:2000;16-22.
99. von Zglinicki T., Saretzki G., Docke W., Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp. Cell Res. 220:1995;186-193.
100. Zhang J., Hess M.W., Thurnher M., Hobisch A., Radmayr C., Cronauer M.V., Hittmair A., Culig Z., Bartsch G., Klocker H. Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markers. Prostate. 30:1997;117-129.
101. Zhu J., Quyyumi A.A., Rott D., Csako G., Wu H., Halcox J., Epstein S.E. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation. 103:2001;1071-1075.